跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,423 条关于
“Balyasny Asset Management”
全部
26,423
临床试验
16,932
药物
141
机构
228
资讯
9,122
去年
Tango Therapeutics Secures $225 Million in Financing to Advance Precision Cancer Medicine Pipeline
3个月前
Oak Hill Bio to Go Public via SPAC Merger, Secures $175 Million to Advance Rugonersen for Angelman Syndrome Through Phase 3
7个月前
TRexBio Secures $50M to Advance Novel Regulatory T Cell Therapy for Atopic Dermatitis
11个月前
Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028
8个月前
Replimune Stock Surges 131% Following FDA Acceptance of Resubmitted RP1 Application for Advanced Melanoma
4个月前
Quince Therapeutics Acquires Orphai for $187M to Advance Inhaled Rapamycin Pipeline for Rare Pulmonary Diseases
上个月
Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial
5个月前
Obsidian and Galera Therapeutics Announce $350 Million Merger to Advance Next-Generation TIL Cell Therapy
2个月前
Jasper Therapeutics Merges with Kira Pharmaceuticals, Secures $132 Million to Advance Complement and Immunology Pipeline
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
第 1 页,共 913 页
上一页
下一页